Skip to main content

Table 1 Patient characteristics

From: The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis

  n = 35
Gender (male) 23 (65.7%)
Age 69 (30–86)
BMI 20.9 (15.5–30.9)
White blood cell (μl) 6340 (3140–12,960)
Neutrophil (μl) 4150 (1380–10,640)
Lymphocyte (μl) 1310 (690–3220)
NLR 2.3 (0.8–7.6)
Hemoglobin (g/dl) 12.2 (7.3–15.7)
Platelet count (× 104/μl) 29.6 (13.1–61.4)
CRP (mg/dl) 0.1 (0.1–13.5)
Total protein (g/dl) 6.7 (4.5–8.2)
Albumin (g/dl) 3.8 (2.1–4.4)
Cholinesterase (U/l) 240 (107–410)
CEA (ng/ml) 2.4 (0.5–1380)
CA19-9 (U/ml) 19.8 (0.5–159.5)
CA125 (U/ml) 11.5 (4.0–247.3)
Tumor differentiation (poorly or signet) 10 (28.6)
Tumor type (3, 4) 31 (88.6%)
Tumor location (UML) 18 (51.4%)
T 4a 28 (80.0%)
N > 2a 18 (51.4%)
clinical Stage II/III/IVa 7 (20.0%)/16 (45.7%)/12 (34.3%)
  1. Values are in n (%) or medians (range)
  2. a7th edition of the American Joint Committee on Cancer (AJCC) [13]
  3. BMI, Body mass index; NLR, neutrophil/lymphocyte ratio; CRP, C-reactive protein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CA125, carbohydrate antigen 125